Blackstone's Spanish gambling company Cirsa net profit falls 11%-March 2024-www.financetom.com

Blackstone's Spanish gambling company Cirsa net profit falls 11%

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Blackstone's Spanish gambling company Cirsa net profit falls 11%

Sep 8, 2025 11:32 PM

Sept 9 (Reuters) - Spanish gambling company Cirsa said on

Tuesday its second quarter net profit fell 11% though it added it was on track

to meet its full-year targets.

Cirsa's quarterly net profit stood at 9.7 million euros ($11.43 million),

down from 10.9 million euros a year ago.

($1 = 0.8490 euros)

(Reporting by Javi West Larrañaga, editing by Inti Landauro)

Previous page： BRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth Profile Next page： Form 8.3 - Dalata Hotel Group PLC

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth Profile

Oct 14, 2025

Oct 14 (Reuters) - Astria Therapeutics Inc ( ATXS ): * BIOCRYST TO ACQUIRE ASTRIA THERAPEUTICS, STRENGTHENING PRESENCE IN HAE, TRANSFORMING GROWTH PROFILE * BIOCRYST PHARMACEUTICALS ( BCRX )- DEAL VALUED AT $13.00 PER ASTRIA SHARE, $700 MILLION ENTERPRISE VALUE * ASTRIA THERAPEUTICS INC ( ATXS ) - BIOCRYST TO PAY $8.55 CASH AND 0.59 SHARES PER ASTRIA SHARE *...

Form 8.3 - Dalata Hotel Group PLC

Oct 14, 2025

LONDON--(BUSINESS WIRE)-- Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed,...

BioCryst to buy Astria Therapeutics in $700 million deal

Oct 14, 2025

Oct 14 (Reuters) - BioCryst Pharmaceuticals ( BCRX ) said on Tuesday it would buy Astria Therapeutics ( ATXS ) in a cash-and-stock deal valued at about $700 million, as it looks to expand its portfolio of treatments for rare diseases. ...

GSK Says China Approves Vaccine for Prevention of Shingles

Oct 14, 2025

07:17 AM EDT, 10/14/2025 (MT Newswires) -- GSK (GSK) said Tuesday that the China National Medical Products Administration has approved Shingrix, its Recombinant Zoster Vaccine for the prevention of shingles, or herpes zoster, in adults aged 18 years and over. The company said its application was informed by six clinical trials in patients aged 18 years and up who had...